Nemes Rush Group’s Teladoc Health TDOC Stock Holding History

Nemes Rush Group’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.08K	Hold	359	–	–	﹤0.01%	758
2026 Q2	$3.04K	Hold	359	–	–	﹤0.01%	730
2026 Q1	$1.96K	Hold	359	–	–	﹤0.01%	750
2025 Q4	$2.51K	Hold	359	–	–	﹤0.01%	702
2025 Q3	$2.78K	Sell	359 -23	-6%	-$180	﹤0.01%	582
2025 Q2	$3.33K	Hold	382	–	–	﹤0.01%	571
2025 Q1	$3.04K	Hold	382	–	–	﹤0.01%	577
2024 Q4	$3.47K	Sell	382 -18	-5%	-$174	﹤0.01%	575
2024 Q3	$6.04K	Buy	400 +18	+5%	+$149	﹤0.01%	449
2024 Q2	$3.74K	Sell	382 -18	-5%	-$220	﹤0.01%	484
2024 Q1	$6.04K	Buy	400 +18	+5%	+$327	﹤0.01%	485
2023 Q4	$8.23K	Hold	382	–	–	﹤0.01%	440
2023 Q3	$7.1K	Hold	382	–	–	﹤0.01%	440
2023 Q2	$9.7K	Buy	+382	New	+$9.6K	﹤0.01%	430

Other funds holding TDOC

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return

Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

TCW Group Los Angeles, California $13B AUM 38.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Nemes Rush Group's TDOC Position: Q3 2026 in Review

Nemes Rush Group held its Teladoc Health (TDOC) position steady in Q3 2026 at 359 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #758.

Nemes Rush Group first reported a position in TDOC in Q2 2023 and has held it in 14 quarters since. The position peaked at $9.7K in Q2 2023. 171 funds tracked by Wall St. Rank hold TDOC as of Q3 2026.

Nemes Rush Group held 359 shares of Teladoc Health worth $2.08K as of Q3 2026.
Nemes Rush Group left its Teladoc Health share count unchanged in Q3 2026.
Teladoc Health made up ﹤0.01% of Nemes Rush Group's portfolio in Q3 2026, its #758 holding.
Nemes Rush Group first reported a position in Teladoc Health in Q2 2023 and has held it in 14 quarters since.
Nemes Rush Group's Teladoc Health position peaked at $9.7K in Q2 2023.
171 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2026.

Based on Nemes Rush Group's 13F filing for Q3 2026, filed 4 Nov 2026.